5th European CAR-T cell Meeting in Rotterdam, 2023

We are excited about the broad spectrum of scientific and clinical developments in the field of CAR T and look forward to the latest insights that will be provided by currently reported clinical data.
We also have something to contribute to this promising tool in cancer cell therapy - our own production of an ingenious plasmid - the minicircle! It is not based on viral vectors, but is more accurate, elegant and innovative because it focuses on the GOI (gene of interest).
The Minicircle has many advantages, not least the decisive factor of its reduced toxicity!
We are pleased to have the opportunity to discuss this important topic with experts.
[email protected]